Sulthiame reduced breathing interruptions in sleep apnea patients, pointing toward a viable drug treatment. A European ...

Intermezzo could help those who wake in the night, but some doctors cautious. April 4, 2012— -- Your eyes snap open, but the room is dark and the alarm clock reads 2 a.m. It's a frustrating but ...

Standard treatment for breathing problems caused by obstructive sleep apnea is a medical device. But many people find it uncomfortable to wear the mask that comes with a continuous positive airway ...

This Nature Outlook is editorially independent, produced with financial support from Avadel. Miranda cannot remember a time in her life when she did not have insomnia. The 23 year old, who asked for ...

The EMA concluded that Melatomed’s benefits outweigh its risks and supported granting marketing authorizations in Germany, Austria, Denmark, and Sweden.

Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said ...

Zepbound is the name of the first drug approved by the FDA for obstructive sleep apnea. According to the Mayo Clinic, obstructive sleep apnea is a common sleep-related breathing disorder that occurs ...

Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone calls earlier this year after the Food and Drug Administration approved ...

A very common medical condition globally, sleep apnea is a disorder that interrupts breathing during sleep. Several factors can cause it, though the risk rises sharply with obesity because extra fat ...

Middle-aged adults and seniors would age more gracefully -- and save a few bucks -- if they lay off prescription sleep medications, a new study says. Avoiding sleep drugs would reduce older Americans' ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking it the first ...

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...